JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1083/jcb.200612046
The Journal of Cell Biology, Vol. 178, No. 2, 201-208
The Rockefeller University Press, 0021-9525 $30.00
© Atfi et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2353K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atfi, A.
Right arrow Articles by Théret, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atfi, A.
Right arrow Articles by Théret, N.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Report

The disintegrin and metalloproteinase ADAM12 contributes to TGF-ß signaling through interaction with the type II receptor



Azeddine Atfi1, Emmanuelle Dumont2, Frédéric Colland3, Dominique Bonnier2, Annie L'Helgoualc'h2, Céline Prunier1, Nathalie Ferrand1, Bruno Clément2, Ulla M. Wewer4, and Nathalie Théret2

1 Institut National de la Santé et de la Recherche Medicale, Unite 673, Hôpital St-Antoine, 75571 Paris, France
2 Institut National de la Santé et de la Recherche Medicale, Unite 620, Institut Federatif de Recherche 140, Université de Rennes I, 35043 Rennes, France
3 Hybrigenics, 75014 Paris, France
4 Department of Biomedicine and Biotech Research and Innovation Centre, University of Copenhagen, DK-1017 Copenhagen, Denmark

Correspondence to Nathalie Théret: nathalie.theret{at}univ-rennes1.fr

Transforming growth factor-ß (TGF-ß) regulates a wide variety of biological processes through two types of Ser/Thr transmembrane receptors: the TGF-ß type I receptor and the TGF-ß type II receptor (TßRII). Upon ligand binding, TGF-ß type I receptor activated by TßRII propagates signals to Smad proteins, which mediate the activation of TGF-ß target genes. In this study, we identify ADAM12 (a disintegrin and metalloproteinase 12) as a component of the TGF-ß signaling pathway that acts through association with TßRII. We found that ADAM12 functions by a mechanism independent of its protease activity to facilitate the activation of TGF-ß signaling, including the phosphorylation of Smad2, association of Smad2 with Smad4, and transcriptional activation. Furthermore, ADAM12 induces the accumulation of TßRII in early endosomal vesicles and stabilizes the TßRII protein presumably by suppressing the association of TßRII with Smad7. These results define ADAM12 as a new partner of TßRII that facilitates its trafficking to early endosomes in which activation of the Smad pathway is initiated.

Abbreviations used in this paper: ADAM, a disintegrin and metalloproteinase; EEA1, early endosomal antigen 1; HSC, hepatic stellate cell; PAI-1, plasminogen activator inhibitor-1; RD, Rhabdomyosarcoma; SARA, Smad anchor for receptor activation; shRNA, short hairpin RNA; TßRII, TGF-ß type II receptor.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents